Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology
NASDAQ | Common Stock
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs.
The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection.
Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment.
The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 30, 21 | -0.17 | - |
| Mar 31, 21 | -0.17 | - |
| Jun 30, 20 | -0.04 | - |
| Mar 31, 20 | -0.04 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 21 | N/A - | N/A - | - - |
| Mar 31, 21 | N/A - | N/A - | - - |
| Jun 30, 20 | N/A - | N/A - | - - |
| Mar 31, 20 | N/A - | N/A - | - - |